PURIFIED I-KAPPA-B-BETA IS INACTIVATED UPON DEPHOSPHORYLATION

被引:0
|
作者
LINK, E
KERR, LD
SCHRECK, R
ZABEL, U
VERMA, I
BAEUERLE, PA
机构
[1] GENE CTR,MOLEC BIOL LAB,KLOPFERSPITZ 18A,O-8033 MARTINSRIED,GERMANY
[2] SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,SAN DIEGO,CA 92138
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In uninduced cells, the NF-kappa-B transcription factor resides in the cytoplasm in complex with an inhibitory protein, I-kappa-B. I-kappa-B is a specific inhibitor of DNA binding and apparently prevents nuclear uptake of NF-kappa-B. Stimulation of cells, for instance with the cytokine tumor necrosis factor, releases I-kappa-B and allows nuclear translocation and DNA binding of NF-kappa-B to regulatory DNA sequences in many genes. We recently reported on the purification of a major form of I-kappa-B, referred to as I-kappa-B-alpha, with a molecular size of 37 kDa. Here, we purified and characterized I-kappa-B-beta, a chromatographically distinct second form of I-kappa-B. I-kappa-B-beta has a size of 43 kDa and, as I-kappa-B-alpha, an acidic isoelectric point between 4.8 and 5.0. Both forms of I-kappa-B were inactivated by a treatment with protein kinases A and C in vitro. In contrast to I-kappa-B-alpha, I-kappa-B-beta lost its inhibiting activity upon a treatment with phosphatase. Phosphatase treatment also released active NF-kappa-B from its inactive complex with I-kappa-B-beta suggesting that the activation of NF-kappa-B in intact cells might not only rely on phosphate transfer onto I-kappa-B but also on phosphate removal from one form of I-kappa-B.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [21] TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I kappa B alpha
    Arsura, M
    Wu, M
    Sonenshein, GE
    IMMUNITY, 1996, 5 (01) : 31 - 40
  • [22] NF-kappa B activation: The I kappa B kinase revealed?
    Stancovski, I
    Baltimore, D
    CELL, 1997, 91 (03) : 299 - 302
  • [23] REL/NF-KAPPA-B/I-KAPPA-B STORY
    MIYAMOTO, S
    VERMA, IM
    ADVANCES IN CANCER RESEARCH, VOL 66, 1995, 66 : 255 - 292
  • [24] Rel/NF-kappa B and I kappa B factors in oncogenesis
    Luque, I
    Gelinas, C
    SEMINARS IN CANCER BIOLOGY, 1997, 8 (02) : 103 - 111
  • [25] Interactions between NF kappa B and its inhibitor i kappa B
    Li, T
    Narhi, LO
    Wen, J
    Philo, J
    Sitney, K
    Inuoe, JI
    Yamamoto, T
    Arakawa, T
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : SU168 - SU168
  • [26] Rel/NF-kappa B and I kappa B proteins: an overview
    May, MJ
    Ghosh, S
    SEMINARS IN CANCER BIOLOGY, 1997, 8 (02) : 63 - 73
  • [27] Rel/NF-kappa B/I kappa B proteins and cancer
    Gilmore, TD
    Koedood, M
    Piffat, KA
    White, DW
    ONCOGENE, 1996, 13 (07) : 1367 - 1378
  • [28] PURIFIED AND INACTIVATED HUMAN HEPATITIS-B VACCINE - PROGRESS REPORT
    HILLEMAN, MR
    BUYNAK, EB
    ROEHM, RR
    TYTELL, AA
    BERTLAND, AU
    LAMPSON, GP
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 270 (02): : 401 - 404
  • [29] Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
    Imbert, V
    Rupec, RA
    Livolsi, A
    Pahl, HL
    Traenckner, EBM
    MuellerDieckmann, C
    Farahifar, D
    Rossi, B
    Auberger, P
    Baeuerle, PA
    Peyron, JF
    CELL, 1996, 86 (05) : 787 - 798
  • [30] Signal-induced degradation of I kappa B alpha: Association with NF-kappa B and the PEST sequence in I kappa B alpha are not required
    VanAntwerp, DJ
    Verma, IM
    MOLECULAR AND CELLULAR BIOLOGY, 1996, 16 (11) : 6037 - 6045